Latest news with #Lund
Yahoo
2 days ago
- Business
- Yahoo
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, June 16, 2025 at 14:00 CEST / 8:00 AM EDT. Pre-registration is required and can be found at this link. Presentations by Dr. David R. Cornblath, MD, Johns Hopkins University School of Medicine and Dr. Simon Rinaldi MRCP (Neuro), PhD, University of Oxford will discuss the unmet need and current treatment landscape for GBS, an acute, rare, paralyzing inflammatory disease of the peripheral nervous system, as well as the role of Immunoglobulin G (IgG) in GBS and recent advancements in science and research. Company management including Hitto Kaufmann, Chief R&D Officer, and Elisabeth Sonesson, VP, Global Franchise Lead Autoimmunity, will highlight current activities and anticipated milestones for the Company in the autoimmune space. A live Q&A will follow the presentations. This is the first in a series of Science Deep Dive virtual events specifically aimed for the investor community and focusing on Hansa's disease areas - Autoimmune, Gene Therapy, and Kidney Transplantation. About David R. Cornblath, MD Dr. David Cornblath received his medical degree from Case Western Reserve University, completed an internship at University Hospitals in Cleveland, Ohio, and neurology residency at the Hospital of the University of Pennsylvania. He served as Clinical Fellow of the Muscular Dystrophy Association at the Peripheral Nerve Morphology Laboratory and then joined the Faculty at Johns Hopkins, rising to rank of Professor and serving as Director of the Neurology EMG Laboratory. Currently retired, Dr. Cornblath continues to consult, serving on safety monitoring boards and clinical trial development programs. He also holds the title of Professor Emeritus of Neurology at Johns Hopkins. About Simon Rinaldi, MRCP(Neuro), PhD Dr. Simon Rinaldi is a clinician scientist and clinical neurologist who leads the University of Oxford's programme of inflammatory neuropathy research. This research spans from in vitro disease modelling using cell-based assays to biomarker discovery, clinical phenotyping, and clinical trials. His lab has developed models of immune mediated axonal injury and demyelination using human induced pluripotent stem cell derived myelinating co-cultures. These experimental systems are now being used to learn more about the mechanisms of immune-mediated peripheral nerve injury, and are a valuable tool in the search for novel auto-antibodies and for the discovery and pre-clinical evaluation of fluid biomarkers. The lab also runs the only UK based diagnostic testing service for nodal and paranodal antibodies, which associate with distinct forms of autoimmune nodopathy, and the underlying B-cell biology of these and related peripheral nerve disorders is a more recent area of study. His research programme also includes a clinical / observational study of chronic inflammatory neuropathy (Bio-SPiN). The group additionally contributes to and benefits from close links with the comprehensive and high-quality clinical-serological database of 2000 patients encapsulated in the International GBS Outcome Study (IGOS) and has been involved in therapeutic trials in Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and multifocal motor neuropathy (MMN). Conference call details To register and to submit questions in advance, please use the following link: To participate in the telephone conference, please use the dial-in details provided below: Participant Dial In (Toll Free): 1-833-821-3542 Participant International Dial In: 1-412-652-1248 The webcast will be available on: Contacts for more information: Evan Ballantyne, Chief Financial OfficerIR@ Stephanie Kenney, VP Global Corporate Affairsmedia@ Notes to editors About Hansa Biopharma Hansa Biopharma AB is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology platform, to address serious unmet medical needs in autoimmune diseases, gene therapy and transplantation. The company's portfolio includes imlifidase, a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients and HNSA-5487, a next-generation IgG cleaving molecule with redosing potential. Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at and follow us on LinkedIn. ©2025 Hansa Biopharma AB. Hansa Biopharma, the beacon logo, IDEFIRIX, and IDEFIRIX flower logo are trademarks of Hansa Biopharma AB, Lund, Sweden. All rights reserved. This information was brought to you by Cision The following files are available for download: 250609 - HNSA Autoimmune Deep Dive 16 June 2025 View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- General
- Yahoo
Chatham 5K proceeds to be donated in crash victim's honor
CHATHAM, Ill. (WCIA) — Proceeds from this year's Chatham Jaycees Sweetcorn Festival 5K will be donated in honor of Bradley Lund, who died on Monday as a result of the April crash into the YNOT after school camp. In a Facebook post on Thursday, Chatham Jaycees said that all of the proceeds from this year's run/walk will be donated to The Backyard at the Library in honor of 8-year-old Bradley Lund and the Lund Family. Lund was the fifth child who died as a result of the crash. Dana-Thomas House Foundation donates $50k for historic Springfield site restoration 'Words cannot express what the Lund family means to our community, our kids, and our organization,' Chatham Jaycees said in its post. They are also strongly encouraging people to register early so that they can order shirts and medals for all the participants. Additionally, Chatham Jaycees has extended the $5 registration discount through June 12. There is also going to be an option to make additional donations on the race's website. The event is family friendly, so participants can run, walk or even push strollers during the race. The 50th annual Sweetcorn Festival 5K will take place from 8-10 a.m. on July 19 at 700 S Main St. Registration ends at 11:59 p.m. on July 15. 'We can't wait to see you in July,' Chatham Jaycees said. 'Let's show up big for Bradley and continue to be together as a community.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Star
6 days ago
- Entertainment
- The Star
BWF explore two more new scoring styles at world juniors in India
BWF secretary general Thomas Lund PETALING JAYA: The Badminton World Federation (BWF) will introduce two new formats at the BWF World Junior Championships in Guwahati, India this October to make the competition more exciting for both players and fans. In partnership with the Badminton Association of India (BAI), the BWF have confirmed that a new relay system will be used in the mixed team event, while a fresh scoring format will be tested in the individual events. The team event will feature a best-of-three games format, with each game played up to 45 points. Each set will consist of five matches, namely men's singles, women's singles, men's doubles, women's doubles and mixed doubles. A version of the relay system was first tried at the 2024 World Junior Mixed Team Championships in China, where it received mixed feedback. BWF have since made improvements based on that feedback. In the individual events, a 3x15 scoring system will be use and this is part of the BWF's ongoing testing programme to explore new formats for the future. Both changes were approved at the BWF Annual General Meeting held in Xiamen, China, in April. BWF secretary general Thomas Lund sees the introduction of the new format as part of the federation's push to modernise badminton by making the game more exciting for fans, without compromising the well-being of the players. "It is essential that this process remains inclusive and well-informed, with any future decision guided by evidence, wide consultation, and what is in the best interest of badminton worldwide. "That's why it is necessary to test such innovations in live tournament settings and it is great that we have the endorsement and backing from our member in India and the city of Guwahati who share the same vision as us," said Lund. To ensure all teams gain a better understanding of the new formats, virtual workshops will be held for team managers and coaches ahead of the World Junior Championships. In addition, BWF will also carry out stakeholder surveys and analyse key match data to guide future decisions regarding the implementation of the new formats.
Yahoo
6 days ago
- Business
- Yahoo
BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK
LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments, including Gas Endeavour® III systems, with a combined value of approximately 0.7 MSEK. CEO Dr. Jing Liu comments: "We are pleased to receive a significant order from a globally recognised research institution. KU Leuven's decision to transition to our technology confirms the value and reliability of our instruments in advanced scientific applications." BPC has received orders from university KU Leuven in Belgium. The value of the orders amounts to approximately 0.7 MSEK and includes several instruments including Gas Endeavour® III. The university is replacing and upgrading its setup for biochemical methane potential (BMP) testing with BPC's instruments for both batch and continuous measurements. The new systems are expected to streamline workflows and provide more precise and reliable data in research related to biological and biochemical gas processes. Revenue from these orders is expected to be recognised in Q2 2025. About Gas Endeavour® III Gas Endeavour® III is an advanced laboratory instrument platform designed for precise evaluation of gas production or consumption measurements in both batch and continuous processes. With its fully automated operation, an intuitive user interface, and high reliability, it offers exceptional ease of use. The system is available with 18 or 9 parallel channels, allowing for the simultaneous evaluation of multiple samples. For more information about Gas Endeavour® III, visit the Gas Endeavour® III product page or contact the sales team at sales@ For more information, please contact: Dr. Jing Liu, CEOBPC Instruments AB Tel: +46 (0) 46 16 39 51 E-mail: ir@ About BPC Instruments AB BPC Instruments is a global Swedish-based pioneering technology company developing and offering analytical instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing analysis. BPC Instruments' innovative products offer high-quality hardware and software based on deep knowledge and experience of target applications. The solutions are the first of their kind, making the company a pioneer in its field. Today, BPC Instruments exports to nearly 80 countries around the world. BPC is listed on the Spotlight Stock Market in Sweden. For more information, please visit BPC's webpage: This information was brought to you by Cision The following files are available for download: Press release - KU Leuven View original content:
Yahoo
7 days ago
- General
- Yahoo
Fifth child dies in Chatham after-school tragedy
SPRINGFIELD, Ill. (WCIA) — The death toll of the car crash at a Chatham after-school program is up to five following the passing of an eight-year-old boy on Monday. Sangamon County Coroner Jim Allmon announced in a news release that Bradley Lund of Springfield passed away after sustaining blunt force injuries in the crash at the YNOT Outdoors program on April 28. Lund had been admitted as a patient at HSHS St. John's Hospital following the crash, and he was still receiving treatment there when he died at 5:52 a.m. on Monday. State Police provide updates on Chatham after-school tragedy The crash also claimed the lives of four girls between the ages of 7 and 18: 7-year-old Kathryn Corley of Chatham 7-year-old Alma Buhnerkempe of Chatham 8-year-old Ainsley Johnson of Chatham 18-year-old Rylee Britton of Springfield Another six children were hospitalized, including Lund. The Illinois State Police concluded its investigation into the crash last week and the Sangamon County State's Attorney's Office began a review to decide on whether charges are warranted against the driver who crashed into YNOT Outdoors' building. In a brief statement to WCIA, State's Attorney John Milhiser said: The tragedy in Chatham is heartbreaking. The Sangamon County State's Attorney's office continues to work with the Illinois State Police on the investigation. John Milhiser Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
